[A reply to Ake Sjoholm et al about new agents against type 2 diabetes: safety data prior to wide utilization or the other way round?].
Karlsson
Eva Andersén
EA
Verksamhetsområde internmedicin, Södersjukhuset AB.
Palmér
Mats
M
Malmström
Rickard
R
D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D019317:Evidence-Based Medicine; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D012449:Safety
D007004:Hypoglycemic Agents